| 2025-12-05 |
详情>>
内部人交易：
EASTHAM KARIN共交易5笔
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本7904.92万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.32美元,归母净利润2520.40万美元,同比去年增长32.48%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘后发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益0.08美元,归母净利润606.70万美元,同比去年增长56.77%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.09美元,归母净利润704.70万美元,同比去年增长478.06%
|
| 2025-04-29 |
股东大会：
将于2025-06-17召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025;
3.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement;
4.To determine, on a non-binding advisory basis, the frequency of advisory votes on the compensation of our named executive officers;
5.To approve an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan;
6.To transact such other business as may properly come before the Annual Meeting and any postponement or adjournment of the Annual Meeting.
|
| 2025-02-28 |
详情>>
业绩披露：
2022年年报每股收益-0.51美元,归母净利润-3656万美元,同比去年增长51.62%
|
| 2025-02-28 |
详情>>
业绩披露：
2024年年报每股收益0.32美元,归母净利润2413.80万美元,同比去年增长132.44%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.25美元,归母净利润1902.50万美元,同比去年增长141.26%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-0.23美元,归母净利润-1649.3万美元,同比去年增长31.26%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益0.05美元,归母净利润387.00万美元,同比去年增长123.46%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益-0.02美元,归母净利润-186.4万美元,同比去年增长76.96%
|
| 2024-04-25 |
股东大会：
将于2024-06-12召开股东大会
会议内容 ▼▲
- 1.To elect two directors to serve until the 2025 annual meeting of stockholders or until their successors are duly elected and qualified.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024.
3.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement.
4.To approve an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan.
5.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-1.02美元,归母净利润-7440.4万美元,同比去年增长-103.51%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.64美元,归母净利润-4611.1万美元,同比去年增长-40.94%
|
| 2023-04-27 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023;
3.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement;
4.To approve our new Veracyte, Inc. 2023 Equity Incentive Plan;
5.To adopt an amendment to our existing restated certificate of incorporation in order to declassify our Board of Directors and make other related changes;
6.To adopt an amendment to our existing restated certificate of incorporation to permit exculpation of officers by Veracyte from personal liability for certain breaches of the duty of care;
7.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2022-04-26 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022;
3.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement;
4.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-23 |
股东大会：
将于2021-06-07召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors to serve until the 2024 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2021;
3.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement;
4.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2020-04-24 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors to serve until the 2023 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To approve the Amended and Restated Veracyte, Inc. Employee Stock Purchase Plan;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2020;
4.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement;
5.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2019-04-24 |
股东大会：
将于2019-06-11召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors to serve until the 2022 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2019;
3.To approve, on a non-binding advisory basis, the compensation paid by us to our named executive officers as disclosed in this Proxy Statement;
4.To select, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two or three years;
5.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2018-04-19 |
股东大会：
将于2018-06-06召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors to serve until the 2021 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2018;
3.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2017-11-07 |
复牌提示：
2017-11-07 09:30:18 停牌，复牌日期 2017-11-07 09:35:18
|
| 2017-04-21 |
股东大会：
将于2017-06-06召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors to serve until the 2020 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2017;
3.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|
| 2016-05-06 |
股东大会：
将于2016-06-17召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors to serve until the 2019 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2016;
3.To transact such other business as may properly come before the Annual Meeting of Stockholders and any postponement or adjournment of the Annual Meeting.
|